Anchiano Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ANCN and buy or sell other stocks, options, and ETFs commission-free!About ANCN
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis.
CEOAdi Mor, PhD
CEOAdi Mor, PhD
Employees20
Employees20
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2011
Founded2011
Employees20
Employees20
ANCN Key Statistics
Market cap66.90M
Market cap66.90M
Price-Earnings ratio-0.28
Price-Earnings ratio-0.28
Dividend yield—
Dividend yield—
Average volume36.81K
Average volume36.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.89
52 Week high$1.89
52 Week low$0.42
52 Week low$0.42